| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.3B | $1.9B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $0.1B | $-0.0B | $-0.2B | — | — |
| Net Income | $-0.1B | $-0.1B | $-0.2B | $0.0B | $-0.0B |
| EPS (Basic) | $-0.30 | $-0.25 | $-0.50 | — | — |
| EPS (Diluted) | $-0.30 | $-0.30 | $-0.51 | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Total Assets | $3.6B | $3.8B | $3.7B | $0.8B | $0.8B |
| Current Assets | $1.3B | $1.4B | $1.2B | $0.0B | $0.0B |
| Cash & Equivalents | $0.5B | $0.5B | $0.3B | $0.0B | $0.0B |
| Total Liabilities | $2.6B | $2.5B | $2.4B | $0.1B | $0.0B |
| Current Liabilities | $0.8B | $0.8B | $0.8B | $0.0B | $0.0B |
| Stockholders' Equity | $1.1B | $1.2B | $0.2B | $-0.1B | $0.0B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $-0.4B | $-0.0B | $-0.0B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $0.0B | $-0.8B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | — | — |
| Financing Cash Flow | $-0.1B | $0.1B | $0.3B | $0.0B | $0.8B |